In the original article, an author name was incorrectly spelled as “Alessandra Bandiera.” The correct spelling is “Alessandra Bandera.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Favalli, E., Gobbini, A., Bombaci, M., Maioli, G., Biggioggero, M., Pesce, E., et al. (2022). Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858) [Altro] [10.3389/fmed.2022.923790].
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858)
Gobbini A.;Favalli A.;Bandera A.;Gori A.;
2022
Abstract
In the original article, an author name was incorrectly spelled as “Alessandra Bandiera.” The correct spelling is “Alessandra Bandera.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
| File | Dimensione | Formato | |
|---|---|---|---|
|
fmed-09-923790.pdf
accesso aperto
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Creative Commons
Dimensione
84.69 kB
Formato
Adobe PDF
|
84.69 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
